NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE119352 Query DataSets for GSE119352
Status Public on Oct 30, 2018
Title High Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune Checkpoint Cancer Therapy
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary Using complementary forms of high dimensional profiling we define differences in CD45+ cells from syngeneic mouse tumors that either grow progressively or eventually reject following immune checkpoint therapy (ICT). Unbiased assessment of gene expression of tumor infiltrating cells by single cell RNA sequencing (scRNAseq) and longitudinal assessment of cellular protein expression by mass cytometry (CyTOF) revealed significant remodeling of both the lymphoid and myeloid intratumoral compartments. Surprisingly, we observed multiple subpopulations of monocytes/macrophages distinguishable by the combinatorial presence or absence of CD206, CX3CR1, CD1d and iNOS, markers of different macrophage activation states that change over time during ICT in a manner partially dependent on IFNγ. Both the CyTOF data and additional analysis of scRNAseq data support the hypothesis that macrophage polarization/activation results from effects on circulatory monocytes/early macrophages entering tumors rather than on pre-polarized mature intratumoral macrophages. Thus, ICT induces transcriptional and functional remodeling of both myeloid and lymphoid compartments.
 
Overall design Droplet-based 3′ end massively parallel single-cell RNA sequencing was performed by encapsulating sorted live CD45+ tumor infiltrating cells into droplets and libraries were prepared using Chromium Single Cell 3′ Reagent Kits v1 according to manufacturer’s protocol (10x Genomics). The generated scRNAseq libraries were sequenced using an Illumina HiSeq2500.
 
Contributor(s) Gubin MM, Esaulova E, Ward JP, Malkova ON, Runci D, Wong P, Noguchi T, Arthur CD, Meng W, Alspach E, Medrano RV, Fronick C, Fehlings M, Newell EW, Fulton RS, Sheehan KF, Oh ST, Schreiber RD, Artyomov MN
Citation(s) 30343900
Submission date Aug 31, 2018
Last update date Nov 22, 2019
Contact name Maxim N. Artyomov
E-mail(s) martyomov@pathology.wustl.edu
Organization name Washington University in St.Louis
Department Immunology&Pathology
Street address 660 S. Euclid Avenue, Campus Box 8118
City St.Louis
State/province MO
ZIP/Postal code 63110
Country USA
 
Platforms (1)
GPL17021 Illumina HiSeq 2500 (Mus musculus)
Samples (4)
GSM3371684 CD45+ cells from tumor microenvironment of IgG2a isotype control antibody treated mice
GSM3371685 CD45+ cells from tumor microenvironment of aPD1 treated mice
GSM3371686 CD45+ cells from tumor microenvironment of aCTLA4 treated mice
Relations
BioProject PRJNA488861
SRA SRP159400

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE119352_RAW.tar 53.7 Mb (http)(custom) TAR (of MTX, TSV)
GSE119352_README.txt 334 b (ftp)(http) TXT
GSE119352_scRNA_lymphoid_meta_data.tsv.gz 123.0 Kb (ftp)(http) TSV
GSE119352_scRNAseq_CD45_meta_data.tsv.gz 348.6 Kb (ftp)(http) TSV
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap